Endothelial fate mapping in mice with pulmonary hypertension

Circulation

Volumn 129, Issue 6, 2014, Pages 692-703

  Qiao, Lina ^c   Nishimura, Toshihiko ^a   Shi, Lingfang ^a   Sessions, Dane ^a   Thrasher, Ama ^a   Trudell, James R ^a   Berry, Gerald J ^b   Pearl, Ronald G ^a   Kao, Peter N ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Cell lineage; Monocrotaline pyrrole; Pneumonectomy; Vascular diseases

Indexed keywords

CELL LINEAGE; MONOCROTALINE PYRROLE; PNEUMONECTOMY; VASCULAR DISEASES;

ACTINS; ALKYLATING AGENTS; ANIMALS; ANTIGENS, CD; CADHERINS; CELL LINEAGE; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INTEGRASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOCROTALINE; NEOINTIMA; PNEUMONECTOMY; PULMONARY ARTERY; VON WILLEBRAND FACTOR;

EID: 84893861830     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.003734     Document Type: Article

References (43)

1. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351:1655-1665.
2. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S20-S31.
3. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958;18:533-547.
4. Stenmark KR, Davie N, Frid M, Gerasimovskaya E, Das M. Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda). 2006;21:134-145.
5. Fishman AP Changing concepts of the pulmonary plexiform lesion. Physiol Res. 2000;49:485-492.
6. Arciniegas E, Ponce L, Hartt Y, Graterol A, Carlini RG. Intimal thickening involves transdifferentiation of embryonic endothelial cells. Anat Rec. 2000;258:47-57.
7. Arciniegas E, Frid MG, Douglas IS, Stenmark KR. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1-L8.
8. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest. 1998;101:927-934.
9. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009;297:L1013-L1032.
10. Lalich JJ, Ehrhart LA. Monocrotaline-induced pulmonary arteritis in rats. J Atheroscler Res. 1962;2:482-492.
11. Merkow L, Kleinerman J. An electron microscopic study of pulmonary vasculitis induced by monocrotaline. Lab Invest. 1966;15:547-564.
12. Mattocks AR. Toxicity of pyrrolizidine alkaloids. Nature. 1968;217:723-728.
13. Plestina R, Stoner HB, Jones G, Butler WH, Mattocks AR. Vascular changes in the lungs of rats after the intravenous injection of pyrrole carbamates. J Pathol. 1977;121:9-18.
14. Shah M, Patel K, Sehgal PB. Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanism. Am J Physiol Cell Physiol. 2005;288:C850-C862.
15. Okada K, Tanaka Y, Bernstein M, Zhang W, Patterson GA, Botney MD. Pulmonary hemodynamics modifly the rat pulmonary artery response to injury: a neointimal model of pulmonary hypertension. Am J Pathol. 1997;151:1019-1025.
16. Nishimura T, Faul JL, Berry GJ, Kao PN, Pearl RG. Effiect of a surgical aortocaval fstula on monocrotaline-induced pulmonary hypertension. Crit Care Med. 2003;31:1213-1218.
17. Nishimura T, Faul JL, Berry GJ, Vaszar LT, Qiu D, Pearl RG, Kao PN. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med. 2002;166:1403-1408.
18. Nishimura T, Vaszar LT, Faul JL, Zhao G, Berry GJ, Shi L, Qiu D, Benson G, Pearl RG, Kao PN. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation. 2003;108:1640-1645.
19. Kao PN. Simvastatin treatment of pulmonary hypertension: an observational case series. Chest. 2005;127:1446-1452.
20. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Cool C, Wood K, Tuder RM, Burns N, Kasper M, Voelkel NF. Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2006;291:L668-L676.
21. Molteni A, Ward WF, Ts'ao CH, Solliday NH. Monocrotaline pneumotoxicity in mice. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;57:149-155.
22. Goto J, Ishikawa K, Kawamura K, Watanabe Y, Matumoto H, Sugawara D, Maruyama Y. Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload. Antioxid Redox Signal. 2002;4:563-568.
23. Aliotta JM, Keaney PJ, Warburton RR, Del Tatto M, Dooner MS, Passero MA, Quesenberry PJ, Klinger JR. Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension. Stem Cells Dev. 2009;18:773-782.
24. Seta F, Rahmani M, Turner PV, Funk CD. Pulmonary oxidative stress is increased in cyclooxygenase-2 knockdown mice with mild pulmonary hypertension induced by monocrotaline. PLoS One. 2011;6:e23439.
25. Cuttica MJ, Langenickel T, Noguchi A, Machado RF, Gladwin MT, Boehm M. Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage. Am J Respir Cell Mol Biol. 2011;45:62-71.
26. Reindel JF, Ganey PE, Wagner JG, Slocombe RF, Roth RA. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Toxicol Appl Pharmacol. 1990;106:179-200.
27. Deyo JA, Reed RL, Buhler DR, Kerkvliet NI. Role of metabolism in monocrotaline-induced immunotoxicity in C57BL/6 mice. Toxicology. 1994;94:209-222.
28. Mattocks AR, Jukes R, Brown J. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon. 1989;27:561-567.
29. Alva JA, Zovein AC, Monvoisin A, Murphy T, Salazar A, Harvey NL, Carmeliet P, Iruela-Arispe ML. VE-cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn. 2006;235:759-767.
30. Faul JL, Nishimura T, Berry GJ, Benson GV, Pearl RG, Kao PN. Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats. Am J Respir Crit Care Med. 2000;162:2252-2258.
31. Nishimura T, Faul JL, Berry GJ, Veve I, Pearl RG, Kao PN. 40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats. Am J Respir Crit Care Med. 2001;163:498-502.
32. Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Filavell RA. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. 2001;193:741-754.
33. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global doublefluorescent Cre reporter mouse. Genesis. 2007;45:593-605.
34. Vaszar LT, Nishimura T, Storey JD, Zhao G, Qiu D, Faul JL, Pearl RG, Kao PN. Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats. Physiol Genomics. 2004;17:150-156.
35. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001;230:230-242.
36. Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, Yang Y, Becker MS, Zanetta L, Dejana E, Gasson JC, Tallquist MD, Iruela-Arispe ML. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell. 2008;3:625-636.
37. Tang Y, Harrington A, Yang X, Friesel RE, Liaw L. The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells. Genesis. 2010;48:563-567.
38. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
39. Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res. 1994;75:803-812.
40. Borrione AC, Zanellato AM, Giuriato L, Scannapieco G, Pauletto P, Sartore S. Nonmuscle and smooth muscle myosin isoforms in bovine endothelial cells. Exp Cell Res. 1990;190:1-10.
41. Romero LI, Zhang DN, Herron GS, Karasek MA. Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells. J Cell Physiol. 1997;173:84-92.
42. Chaudhuri V, Karasek MA. Mechanisms of microvascular wound repair, II: injury induces transformation of endothelial cells into myofibroblasts and the synthesis of matrix proteins. In Vitro Cell Dev Biol Anim. 2006;42:314-319.
43. Karasek MA. Does transformation of microvascular endothelial cells into myo fibroblasts play a key role in the etiology and pathology of fibrotic disease? Med Hypotheses. 2007;68:650-655.